Nexalin Technology, Inc. Common Stock (NXL) Stock Price

NXLStock

$0.25−72.76%52W

Market Cap$6.42M

P/E—

PEG Ratio—

Div yield—

Beta3.98

NXL Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-67.59%

Price vs S&P 500 (4W)-33.03%

VGM Score25.69

Book Value / Share (Quarterly)$0.14

P/TBV (Annual)10.39x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-38.88%

Cash Flow / Share (Quarterly)$-0.26

Price vs S&P 500 (YTD)-68.02%

Gross Margin (TTM)81.99%

Net Profit Margin (TTM)-3022.86%

EPS (TTM)$-0.46

10-Day Avg Trading Volume0.24M

EPS Excl Extra (TTM)$-0.46

Revenue Growth (5Y)4.43%

EPS (Annual)$-0.50

ROI (Annual)-206.94%

Gross Margin (Annual)79.66%

Net Profit Margin (5Y Avg)-3155.40%

Cash / Share (Quarterly)$0.13

Revenue Growth QoQ (YoY)-63.55%

ROA (Last FY)-180.15%

Revenue Growth TTM (YoY)110.34%

EBITD / Share (TTM)$-0.47

Operating Margin (TTM)-3084.13%

Cash Flow / Share (Annual)$-0.30

P/B Ratio2.67x

P/B Ratio (Quarterly)2.48x

Net Income / Employee (Annual)$-1,027,800

EV / Revenue (TTM)23.60x

Net Interest Coverage (TTM)-27.58x

ROA (TTM)-166.45%

EPS Incl Extra (Annual)$-0.50

Current Ratio (Annual)7.25x

Quick Ratio (Quarterly)3.40x

3-Month Avg Trading Volume0.48M

52-Week Price Return-72.76%

Revenue / Employee (TTM)$34,400

Tangible BV / Share (Quarterly)$0.12

P/S Ratio (Annual)25.57x

Asset Turnover (Annual)0.04x

52-Week High$2.00

Operating Margin (5Y Avg)-3252.44%

EPS Excl Extra (Annual)$-0.50

CapEx CAGR (5Y)121.02%

26-Week Price Return-55.66%

Quick Ratio (Annual)6.39x

13-Week Price Return-57.19%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)4.07x

Enterprise Value$6.50M

Revenue / Share Growth (5Y)-11.24%

Asset Turnover (TTM)0.06x

Revenue / Employee (Annual)$37,700

Inventory Turnover (Annual)0.22x

Pretax Margin (Annual)-2725.74%

Cash / Share (Annual)$0.26

3-Month Return Std Dev103.02%

Gross Margin (5Y Avg)78.47%

Net Income / Employee (TTM)$-1,041,300

ROE (Last FY)-206.94%

Net Interest Coverage (Annual)-27.97x

EPS Basic Excl Extra (Annual)$-0.50

Receivables Turnover (TTM)9.59x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.46

Receivables Turnover (Annual)15.06x

ROI (TTM)-191.88%

P/S Ratio (TTM)27.99x

Pretax Margin (5Y Avg)-3155.40%

Revenue / Share (Annual)$0.02

Tangible BV / Share (Annual)$0.26

Price vs S&P 500 (52W)-91.32%

Year-to-Date Return-55.20%

5-Day Price Return-20.74%

EPS Normalized (Annual)$-0.50

ROA (5Y Avg)-801.91%

Net Profit Margin (Annual)-2725.74%

Month-to-Date Return-25.99%

Cash Flow / Share (TTM)$-0.63

EBITD / Share (Annual)$-0.51

Operating Margin (Annual)-2781.66%

LT Debt / Equity (Annual)0.00x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.46

P/TBV (Quarterly)2.84x

P/B Ratio (Annual)9.66x

Inventory Turnover (TTM)0.28x

Pretax Margin (TTM)-3022.86%

Book Value / Share (Annual)$0.28

Price vs S&P 500 (13W)-59.15%

Beta3.98x

Revenue / Share (TTM)$0.01

ROE (TTM)-191.88%

52-Week Low$0.22

vGradeD

gGradeC

mGradeF

vgmGradeD

NXL Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 12, 2026	-$0.10	-$0.11	-10.00%(-$0.01)
Q1 2026	May 8, 2026	-$0.10	-$0.11	-10.00%(-$0.01)
Q4 2025	Mar 25, 2026	-$0.12	-$0.13	-8.33%(-$0.01)
Q3 2025	Nov 14, 2025	-$0.12	-$0.13	-8.33%(-$0.01)
Q2 2025	Aug 6, 2025	-$0.14	-$0.10	+28.57%(+$0.04)

NXL Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

Industry Peers — Electromedical Equipment(31)

Symbol	Value Score	Growth Score	Momentum Score	Price
NXLNexalin Technology, Inc. Common Stock	D	C	F	$0.25
MDTMedtronic plc	B	C	C	$91.23
LIVNLivaNova PLC Ordinary Shares	C	B	B	$80.32
ITGRInteger Holdings Corporation	C	C	B	$125.33
TMDXTransMedics Group, Inc. Common Stock	C	B	C	$88.43
AXGNAxogen, Inc. Common Stock	F	B	A	$51.47
BLFSBioLife Solutions Inc.	D	C	B	$36.38
CNMDCONMED Corporation	B	C	B	$49.98
CBLLCeriBell, Inc. Common Stock	D	A	B	$23.73
INMDInMode Ltd. Ordinary Shares	A	D	C	$14.85
CVCapsoVision, Inc. Common Stock	F	D	B	$5.93
ELMDElectromed, Inc.	D	B	C	$29.60
FOCLEDAP TMS S.A. American Depositary Shares	C	C	A	$4.31
STEXStreamex Corp. Common Stock	—	C	D	$0.77
STXSStereotaxis, Inc. Common Stock	D	D	D	$1.45
VANIVivani Medical, Inc. Common Stock (DE)	—	—	B	$1.42
HYPRHyperfine, Inc. Class A Common Stock	C	A	D	$0.83
ECORelectroCore, Inc. Common Stock	C	A	B	$9.63
NRXSNeuraxis, Inc.	F	B	B	$6.00
OMOutset Medical, Inc. Common Stock	A	C	D	$3.94
POCIPrecision Optics Corporation, Inc. Common Stock	C	A	C	$4.40
QTIQT Imaging Holdings, Inc. Common Stock	D	A	F	$3.09
IRIXIridex Corp	B	D	D	$0.71
ITOCiTonic Holdings Ltd Class A Ordinary Shares	—	A	C	$0.32
NDRAENDRA Life Sciences Inc. Common Stock	D	—	B	$5.00
NUWENuwellis, Inc. Common Stock	A	D	F	$0.89
EDAPEDAP TMS SA	C	B	B	$4.34
EYESCorgi Data & Surveillance ETF	—	C	B	$30.10
FONRFonar Corporation	B	D	B	$0.00
MASIMasimo Corporation	D	D	C	$0.00
QSIAWQuantum-Si Incorporated Warrant	—	—	F	$0.00
TIVCTivic Health Systems, Inc. Common Stock	—	B	F	$0.12

About Nexalin Technology, Inc. Common Stock

Nexalin Technology develops bioelectronic neurostimulation devices for treating anxiety and insomnia without medications or psychotherapy. The company's Generation 1 product is a cranial electrotherapy stimulation (CES) device that delivers targeted neural stimulation. As a Class II FDA-cleared device, it represents a non-pharmacological treatment option in the mental health care market.